CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Jul 20, 2026--
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announces the first commercial launch of its innovative auto-loading, dosing dropper technology called NeoDropper Autoload. Aptar’s technology is featured on Dermalogica’s FutureCode Booster skincare product. Designed for prestige skincare and dermocosmetic brands, this next-generation dropper packaging is intended to address consumer needs around dosage control, convenience and clean usage by supporting precision dispensing and user experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260720314180/en/
Aptar’s NeoDropper Autoload reinvents the dropper experience by combining a twist-and-push dispensing mechanism and auto-loading dropper cap which automatically loads the applicator with consistent dose after each use. The unique, short applicator design is intended to prevent breakage while improving hygiene and dosage control. The dip tube inside the bottle is designed to allow consumers to use the formula until the last drop and help minimize formula waste.
“We are advancing dropper and dosing packaging innovation to address evolving market needs and shape the future of precision dispensing for forward-thinking skincare brands,” said Xavier Joseph, Vice President, Global Marketing and Innovation, Aptar Beauty.
Clinical skincare brands continue to gain traction in the U.S. beauty market* due to consumers seeking clinically validated products. This is why beauty brands are increasingly turning to advanced dispensing technologies to preserve formulas, which are incorporating potent ingredients and actives that require protection and dosage accuracy.
NeoDropper Autoload intends to address this market shift through a next-generation dropper technology engineered to enhance formula integrity, hygiene and dispensing precision to minimize product loss.
Professional-grade skincare brand, Dermalogica, selected NeoDropper Autoload for the new FutureCode Booster serum, an advanced longevity treatment designed to reverse daily DNA-related damage and defend against visible skin aging.
According to Manuela DeForge, Packaging Engineer Manager at Dermalogica, “FutureCode Booster has been positively received by consumers, particularly for its dispensing performance, ease of use, and overall user experience. Feedback highlights the value of delivering a consistent dose in a controlled and hygienic manner, demonstrating how thoughtful packaging design can enhance both product performance and everyday usability.”
This launch marks the latest milestone in the longstanding collaboration between Dermalogica and Aptar, reflecting a shared ambition to promote product performance and consumer experience through packaging innovation. In 2022, Dermalogica became the first prestige skincare brand to feature Aptar’s fully recyclable mono-material polyethylene dispensing pump (when paired with a PE or PET bottle), called Future, thus advancing the product circularity of its cleansing range.
*Circana, U.S. Beauty Market Skincare, Q1 2026.
About Aptar
Aptar is a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing. Aptar partners with the world’s top healthcare and consumer brands to deliver medicines and create exceptional user experiences. Serving diverse markets, from pharmaceutical to beauty to food and beverage, Aptar combines market expertise with proprietary design, engineering and science to develop innovative solutions that help improve lives worldwide. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 dedicated people across 20 countries. Learn more at http://www.aptar.com.
This press release contains forward-looking statements, including with regard to the expected performance and benefits of Aptar’s NeoDropper Autoload technology, including formula protection, dispensing precision and consistency, hygienic use and consumer experience; anticipated market acceptance and related commercial opportunities for the technology and products incorporating it. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by use of words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential,” “continues” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: whether the technology and products incorporating it perform as expected; demand for and market acceptance of new products and technologies; customer and consumer preferences; our ability to develop, commercialize, manufacture and protect our technologies and products; product performance, quality or supply chain matters; the successful integration of acquisitions; the regulatory environment; and competition, including technological advances. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K and Form 10-Qs. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Aptar's auto-loading, dosing dropper technology, NeoDropper Autoload, featured on Dermalogica's FutureCode Booster
